These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18198420)

  • 21. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia.
    McKracken E; Graham DI; Nilsen M; Stewart J; Nicoll JA; Horsburgh K
    Brain Pathol; 2001 Oct; 11(4):414-21. PubMed ID: 11556686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
    Vincent B; Smith JD
    Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.
    Näslund J; Thyberg J; Tjernberg LO; Wernstedt C; Karlström AR; Bogdanovic N; Gandy SE; Lannfelt L; Terenius L; Nordstedt C
    Neuron; 1995 Jul; 15(1):219-28. PubMed ID: 7619525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies.
    Barger SW; DeWall KM; Liu L; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):773-83. PubMed ID: 18648325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
    Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
    Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia.
    Horsburgh K; Graham DI; Stewart J; Nicoll JA
    J Neuropathol Exp Neurol; 1999 Mar; 58(3):227-34. PubMed ID: 10197814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain.
    Jendroska K; Poewe W; Daniel SE; Pluess J; Iwerssen-Schmidt H; Paulsen J; Barthel S; Schelosky L; Cervós-Navarro J; DeArmond SJ
    Acta Neuropathol; 1995; 90(5):461-6. PubMed ID: 8560978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.
    Cai Z; Liu Z; Xiao M; Wang C; Tian F
    Neurochem Res; 2017 Dec; 42(12):3446-3455. PubMed ID: 28836062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
    Shackleton B; Crawford F; Bachmeier C
    Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.
    Ishii K; Tamaoka A; Mizusawa H; Shoji S; Ohtake T; Fraser PE; Takahashi H; Tsuji S; Gearing M; Mizutani T; Yamada S; Kato M; St George-Hyslop PH; Mirra SS; Mori H
    Brain Res; 1997 Feb; 748(1-2):250-2. PubMed ID: 9067471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.
    Salminen A; Kauppinen A; Kaarniranta K
    J Neurochem; 2017 Feb; 140(4):536-549. PubMed ID: 27987381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
    Russo C; Angelini G; Dapino D; Piccini A; Piombo G; Schettini G; Chen S; Teller JK; Zaccheo D; Gambetti P; Tabaton M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15598-602. PubMed ID: 9861015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.